Inactive Instrument
Biondvax Pharmaceuticals Ltd Stock Other OTC
Stocks
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Amir Reichman
CEO | Chief Executive Officer | 51 | 2021-03-01 |
Uri Ben-Or
DFI | Director of Finance/CFO | 55 | 2006-12-31 |
Dalit Fischer
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Germain
CHM | Chairman | 77 | 2019-09-29 |
Samuel Moed
BRD | Director/Board Member | 64 | 2020-03-23 |
Adi Raviv
BRD | Director/Board Member | 71 | 2020-03-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 38.98M | |
| -1.16% | -2.77% | -1.68% | +13.85% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +527.30% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +22.37% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +77.49% | 40.73B | |
| -0.96% | -2.31% | +15.75% | +45.41% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +120.75% | 16.5B | |
| -1.54% | -1.30% | +12.02% | +31.14% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.12% | 13.77B | |
| Average | -0.86% | +0.48% | +73.69% | +109.93% | 30.55B | |
| Weighted average by Cap. | -0.95% | +0.05% | +89.18% | +128.66% |
